Circulating Immune Complexes in Lyme Arthritis: DETECTION BY THE 125I-C1q BINDING, C1q SOLID PHASE, AND RAJI CELL ASSAYS
AUTOR(ES)
Hardin, John A.
RESUMO
We have found immunoglobulin (Ig) G-containing material consistent with immune complexes in the sera of patients with Lyme arthritis. It was detected in 29 of 55 sera (55%) from 31 patients by at least one of three assays: 125I-C1q binding, C1q solid phase, or Raji cell. The presence of reactive material correlated with clinical aspects of disease activity; it was found early in the illness, was most prominent in sera from the sickest patients, was infrequent during remissions, and often fluctuated in parallel with changes in clinical status. The results in the two C1q assays showed a strong positive correlation (P<0.001). They were each elevated in 45% of the sera and were usually concordant (85%). In contrast, the Raji cell assay was less frequently positive and often discordant with the C1q assays. In sucrose density gradients, putative circulating immune complexes sedimented near 19S; they, too, were detected best by the two assays based on C1q binding. An additional 7S component was found in some sera by the 125I-C1q binding assay. Serum complement was often above the range of normal in patients with mild disease and normal in patients with severe disease but did not correlate significantly with levels of circulating immune complexes. IgM and IgG rheumatoid factors were not detectable.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=371975Documentos Relacionados
- Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis.
- Circulating Immune Complexes after Renal Transplantation: CORRELATION OF INCREASED 125I-C1q BINDING ACTIVITY WITH ACUTE REJECTION CHARACTERIZED BY FIBRIN DEPOSITION IN THE KIDNEY
- Circulating and intra-articular immune complexes in rheumatoid arthritis: a comparative study of the C1q binding and monoclonal rheumatoid factor assays.
- Inhibition of direct binding of enzyme-conjugated antihuman IgG t C1q using dextran sulphate in solid phase assays for immune complexes.
- Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.